A study by Jiang et al showed that high expression of TYRO3 could induce tumor cell resistance to anti-PD-1/PD-L1 therapy by upregulating genes that block ferroptosis and downregulating genes inducing ferroptosis, thus inhibiting ferroptosis. The gene discussed is TYRO3; the disease is neoplasm.